New Study Confirms Power of Real-World Data in Proactive Signal Detection, Improving Patient Safety
Boston, Massachusetts, USA – November 8, 2023 – ArisGlobal, creator ...
New ArisGlobal Office in Mysore Signals Commitment to the Region
"This investment is a reflection of our dedication to our ...
Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions
Pharmaceutical company intends to digitize safety processes with LifeSphere Safety’s ...
ArisGlobal to Relocate Global Headquarters to Boston Area
Move reflects the growth needs and geographically positions the life ...
ArisGlobal Enhances Leadership Team with Two C-Suite Appointments and Advances Global Operating Model
Executive additions and operational enhancements support the company’s significant growth ...
ArisGlobal Acquires Leading Regulatory Data Solution SPORIFY
The acquisition enhances ArisGlobal LifeSphere Regulatory solutions with robust data ...
ArisGlobal Strengthens Leadership Team with Addition of Chief Marketing Officer
Information industry veteran Julie Springer joins Aris Global as first ...
Drug Development Technology Leader ArisGlobal Completes Acquisition of Amplexor Life Sciences
The deal introduces Quality Management functionalities into LifeSphere’s product ecosystem, ...
Breakthrough, ArisGlobal’s Signature Life Sciences Thought Leadership Summit, Heads to Chicago
The annual event brings together leading innovators from global top ...
ArisGlobal Expands Market-Leading Safety Portfolio to Manage Pharmacovigilance Documents and Data
Available with out-of-the-box binders for Pharmacovigilance System Master File and ...
